# Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease

Study · id `cardio:ct-nct02369549` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02369549](<https://clinicaltrials.gov/study/NCT02369549>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02369549

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 518 participants.

## Technical summary

Registry record NCT02369549. Randomized; quadruple masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2019-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 518 participants (enrolled count; ClinicalTrials.gov record NCT02369549, source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)
- Started: 2015-09 (actual) (ClinicalTrials.gov record NCT02369549, source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)
- Primary completion: 2019-11 (actual) (ClinicalTrials.gov record NCT02369549, source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)
- Completion: 2020-05-15 (actual) (ClinicalTrials.gov record NCT02369549, source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02369549, source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02369549-2021-01-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
- Acronym: MPAC-CKD
- Condition: Chronic Kidney Disease
- Intervention (Drug): Micro-particle Curcumin
- Intervention (Drug): Placebo
- Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Lead sponsor class: OTHER
- Collaborator: The Kidney Foundation of Canada
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (`cardio:org-london-health-sciences-centre-research-institute-or-lawson-92e6ca`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial (`cardio:pubmed-36849161`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2fd570050375e22c0bb309a853d2f8e757445d2a1ba9eceb01201d0831be0a33
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
